This study of 1,358 children investigated whether intermittent montelukast -- a drug widely used to treat wheeze and other asthmatic symptoms -- compared with placebo, reduced wheezing episodes in children aged 10 months to 5 years, and whether patient outcome differed according to genotype.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/y...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/y...